Hangzhou Tigermed Consulting (03347): As of the end of August, a total of 20.9635 million A-shares have been repurchased.

date
17:31 01/09/2026
avatar
GMT Eight
Tigermed (03347) announced that as of August 31, 2026, the company repurchased 20.9635 million shares through a special stock repurchase account via centralized bidding, accounting for 2.4347% of the company's current total share capital and 2.8410% of the current A-share capital. The highest transaction price was 42.78 yuan per share, the lowest transaction price was 38.22 yuan per share, and the total transaction amount was 824 million yuan (excluding transaction costs). This repurchase is in compliance with the company's share repurchase plan and relevant laws and regulations.
Hangzhou Tigermed Consulting (03347) announced that as of August 31, 2026, the company repurchased a total of 20,963,500 shares through a dedicated securities account for stock repurchase via centralized bidding, accounting for 2.4347% of the company's current total share capital and 2.8410% of the total A-share capital. The highest transaction price was 42.78 yuan per share, and the lowest transaction price was 38.22 yuan per share, with a total transaction amount of 824 million yuan (excluding transaction fees). This repurchase complies with the company's share repurchase plan and related laws and regulations.